Package 69547-353-02

Brand: narcan

Generic: naloxone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 69547-353-02
Digits Only 6954735302
Product NDC 69547-353
Product ID 69547-353_4536fef4-e317-a7fd-e063-6294a90aa0e3
Description

2 VIAL, SINGLE-DOSE in 1 PACKAGE (69547-353-02) / .1 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Discontinued 2026-05-31
Brand narcan
Generic naloxone hydrochloride
Sample Package No

Linked Drug Pages (1)

Narcan ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["NASAL"], "spl_id": "4536fef4-e317-a7fd-e063-6294a90aa0e3", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1725059", "1725064"], "spl_set_id": ["724df050-5332-4d0a-9a5f-17bf08a547e1"], "manufacturer_name": ["Emergent Devices Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 VIAL, SINGLE-DOSE in 1 PACKAGE (69547-353-02)  / .1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "69547-353-02", "marketing_end_date": "20260531", "marketing_start_date": "20170124"}], "brand_name": "Narcan", "product_id": "69547-353_4536fef4-e317-a7fd-e063-6294a90aa0e3", "dosage_form": "SPRAY", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "69547-353", "generic_name": "Naloxone Hydrochloride", "labeler_name": "Emergent Devices Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Narcan", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": "4 mg/.1mL"}], "application_number": "NDA208411", "marketing_category": "NDA", "marketing_start_date": "20170124", "listing_expiration_date": "20261231"}